Big Ten Cancer Consortium Meets in Indy
The Big Ten Cancer Research Consortium was created in 2013.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowBig Ten cancer center researchers are in Indianapolis today and tomorrow for a first-ever cancer research summit among the institutions. Organizers say biotech and pharmaceutical industry leaders will take part in the event to explore new collaboration opportunities.
The Indiana University Melvin and Bren Simon Cancer Center is hosting the summit at the JW Marriott Indianapolis. Researchers from the IU Simon Cancer Center and the Purdue University Center for Cancer Research will lead presentations on drug development and cell metabolism, while industry leaders will discuss how industry and higher education can work together on future therapies.
The Big Ten Cancer Research Consortium was created in 2013. It opened its first clinical trial in March 2015 and completed enrollment in July 2016, ab out six months ahead of schedule. Together, the Big Ten cancer centers support the work of 2,600 cancer researchers and care for more than 50,000 new cancer patients each year.
The consortium consists of:
University of Illinois Cancer Center
Indiana University Melvin and Bren Simon Cancer Center
Holden Comprehensive Cancer Center, University of Iowa
University of Michigan Comprehensive Cancer Center
Michigan State University Breslin Cancer Center
Masonic Cancer Center, University of Minnesota
Fred & Pamela Buffet Cancer Center, University of Nebraska
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Penn State Cancer Institute
Purdue University Center for Cancer Research
Rutgers Cancer Institute of New Jersey
University of Wisconsin Carbone Cancer Center
